Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities | ACS Nano
Associations between alcohol consumption and gray and white matter volumes in the UK Biobank | Nature Communications
Glassfrogs conceal blood in their liver to maintain transparency | Science
Simple linear measurements of the normal liver: interobserver agreement and correlation with hepatic volume on MRI. | Semantic Scholar
A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis | Nature Communications
Turning the Page: Advancing Paper-Based Microfluidics for Broad Diagnostic Application | Chemical Reviews
Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates | Nature Communications
Age-Related Gene Expression Signature in Rats Demonstrate Early, Late, and Linear Transcriptional Changes from Multiple Tissues - ScienceDirect
Cellulose - Wikipedia
![Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...](https://pubs.acs.org/cms/10.1021/jm4019299/asset/images/large/jm-2013-019299_0014.jpeg "Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...")
Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of ...
Semi-automatic liver segmentation based on probabilistic models and anatomical constraints | Scientific Reports
PDF) Fibrinogen measurement in liver disease: Validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model
The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease. | Semantic Scholar
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis - The Lancet Gastroenterology & Hepatology
Cream Linear – Arthouse
Associations of body shape index (ABSI) and hip index with liver, metabolic, and inflammatory biomarkers in the UK Biobank cohort | Scientific Reports
Ask a Internal Medicine Online for Glycogen Storage Disorder
Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease | Gene Therapy
Convergent somatic mutations in metabolism genes in chronic liver disease | Nature
Polysaccharide - Wikipedia
Multi-organ imaging demonstrates the heart-brain-liver axis in UK Biobank participants | Nature Communications
![PDF] A natural 4-parameter family of covariance functions for stationary Gaussian processes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c08c71ffe13c0999a23cd6d50d52dd959217ec17/5-Figure1-1.png "PDF] A natural 4-parameter family of covariance functions for stationary Gaussian processes | Semantic Scholar")
PDF] A natural 4-parameter family of covariance functions for stationary Gaussian processes | Semantic Scholar
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Gastroenterology & Hepatology
Illustrated Guide to Transformers- Step by Step Explanation | by Michael Phi | Towards Data Science
